2017
DOI: 10.1155/2017/7825942
|View full text |Cite
|
Sign up to set email alerts
|

Corrigendum to “Metalloproteinases and Their Tissue Inhibitors in Comparison between Different Chronic Pneumopathies in the Horse”

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 1 publication
0
1
0
Order By: Relevance
“…MiR-146-5p targets inflammatory mediators like COX2, IL-1β, KIT, NFKB1, TLR4, TRAF6 , and UHRF1 [ 78 ] and has been proposed as a predictor for asthma exacerbations in childhood asthma [ 79 , 80 ]. The anti-inflammatory miR-135b acts by targeting FOXN3 and RECK , an inhibitor of MMP2, and the known sEA pathogenesis factor MMP9 [ 81 , 82 , 83 ]. These anti-inflammatory actions might be the immunological counterbalance, and thus the defense mechanism of the lung against acute inflammation (likely Th17-mediated, as outlined above) during disease exacerbation.…”
Section: Discussionmentioning
confidence: 99%
“…MiR-146-5p targets inflammatory mediators like COX2, IL-1β, KIT, NFKB1, TLR4, TRAF6 , and UHRF1 [ 78 ] and has been proposed as a predictor for asthma exacerbations in childhood asthma [ 79 , 80 ]. The anti-inflammatory miR-135b acts by targeting FOXN3 and RECK , an inhibitor of MMP2, and the known sEA pathogenesis factor MMP9 [ 81 , 82 , 83 ]. These anti-inflammatory actions might be the immunological counterbalance, and thus the defense mechanism of the lung against acute inflammation (likely Th17-mediated, as outlined above) during disease exacerbation.…”
Section: Discussionmentioning
confidence: 99%